Skip To Main Content
James C on Muck Rack

James C

As seen in: Oxford University Press (OUP), Frontiers, Journal of Financial Economics, MDPI, ACS Publications, Cancer Research, FUTURES, International Journal of Forecasting

Get in touch with James

Contact James, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

James C’s Biography

Read Full Bio →

Native to the lands of New York, Studied Anthropology at SUNY Albany, but that doesn't define me. Always seeking out adventures big and small, seeing what this earth has to offer.

Articles

SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell Carcinoma. Open Access

|
By James C
| Cancer Research Verified
Open figure viewer This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License .
Open in Who Shared Issue with article?

[2602.16090] Examining Fast Radiative Feedbacks Using Machine-Learning Weather Emulators

|
By James C
| arxiv.org
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Open in Who Shared View Duplicates (472) Issue with article?

Image guided energy-based ablation of T1 renal cell cancer: a ten-year single centre experience - CVIR Oncology

|
By James C, College Dublin
| link.springer.com
Abstract Image-guided energy-based tumour ablation (IGTA) with radiofrequency ablation (RFA), microwave ablation (MWA) and cryotherapy are curative local therapies for T1 renal cell carcinoma (RCC). The aim of this study is to evaluate the oncological outcomes and survival after IGTA of T1 RCC in our unit over a 10-year period. We retrospectively reviewed all patients with biopsy proven RCC who underwent IGTA of a T1 tumour between 1st March 2013 and 1st June 2023.
Open in Who Shared Issue with article?
See all 23 licensed articles (25 Total)